Cited by 301Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Increased levels of granular tau oligomers: An early sign of brain aging and Alzheimer's disease

Maeda, Sumihiro, Sahara, Naruhiko, Saito, Yuko, Murayama, Shigeo, Ikai, Atsushi, Takashima, Akihiko·2006·Neuroscience Research

Abstract

Development of neurofibrillary tangles (NFTs) is a pathological hallmark in various neurodegenerative disorders including Alzheimer's disease (AD). Recently, we identified a granular tau oligomer having a pre-filamentous structure. To determine the role of this oligomer in NFT formation, we quantified the amount of granular tau oligomer in 21 frontal cortex samples, each displaying varying degrees of Braak-staged NFT pathology. Here we report that granular tau oligomer levels in frontal cortex were significantly increased, even in brains displaying Braak-stage I neuropathology, a stage at which clinical symptoms of AD and NFTs in frontal cortex are believed to be absent. This suggests that increases in granular tau oligomer levels occur before NFTs form and before individuals manifest clinical symptoms of AD. Increased granular tau oligomer levels, therefore, may lead to NFT formation in frontal cortex, eventually leading to the development of AD. Thus, increases in granular tau oligomer levels may represent a very early sign of NFT formation and AD.

Integrity signals

Registry

Crossref · 10.1016/j.neures.2005.11.009

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 23 · Cited by 301

Authors
Maeda, S., Sahara, N., Saito, Y., Murayama, S., Ikai, A., & Takashima, A.
Affiliations
  • Tokyo Institute of Technology (JP)
  • RIKEN Center for Brain Science (JP)
  • Tokyo Metropolitan Institute of Gerontology (JP)
Corresponding author
Takashima, Akihiko
Venue
Neuroscience Research
Publisher
Elsevier BV
Published
2006-03
Volume
54
Issue
3
Pages
197-201
ISSN
0168-0102 (ISSN-L)
OpenAlex
W2092704615
Cited by
301
References
23
Citations by year
2026: 10 · 2025: 9 · 2024: 14 · 2023: 16 · 2022: 15 · 2021: 23 · 2020: 25 · 2019: 12 · 2018: 14 · 2017: 14 · 2016: 14 · 2015: 18 · 2014: 21 · 2013: 18 · 2012: 20
FWCI
7.07
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroscience Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
neurofibrillary tangles, Alzheimer's disease, brain aging, Braak staging, frontal cortex, early biomarkers, neurodegeneration
MeSH terms
Aged, Aged, 80 and over, Aging, Alzheimer Disease, Brain, Female, Humans, Male, Middle Aged, Blotting, Western, Neurofibrillary Tangles, tau Proteins, Microscopy, Atomic Force

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review